Annual report
4272.TEDINET S100YD4R
Period2025-04-01 → 2026-03-31
Filed2026-06-19
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 152
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥241.9bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥222.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥201.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥198.4bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥184.8bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥22.5bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥20.4bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥25.5bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥22.3bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥12.6bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥23.0bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥23.2bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥33.6bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥22.0bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥24.6bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥17.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.1bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥15.0bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥17.2bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥24.7bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥17.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥398.7bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥373.7bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥363.2bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥322.9bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥315.5bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥118.6bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥105.2bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥280.1bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥268.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥270.5bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥255.0bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥246.4bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥50.0bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥55.4bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥53.4bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥57.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.1bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥53.0bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥28.8bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥25.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.2bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥20.0bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥23.1bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥17.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥27.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥19.4bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥15.2bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.6bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥20.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥8.0bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥11.1bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥161.18 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥107.17 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.8 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.36 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.7 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥161.18 | 2025-04-01 → 2026-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥107.16 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥24.79 | 2023-04-01 → 2024-03-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥89.33 | 2022-04-01 → 2023-03-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥101.65 | 2021-04-01 → 2022-03-31v | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,878.87 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,673.24 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,625.18 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,532.35 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,459.06 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 70.0% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.2% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.8% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.0% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.5% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 1.6% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 5,946 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 5,979 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 5,902 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 5,782 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 5,703 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥145.1bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥130.5bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥120.5bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥128.0bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥124.0bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥9.2bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥4.5bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥28.8bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥13.0bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.6bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥17.2bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.1bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥36.9bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥12.8bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥30.8bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥11.4bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | −¥666m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥12.6bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥12.6bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥280.7bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥265.4bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥261.6bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥237.5bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥236.4bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥100.6bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥88.1bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥180.0bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥177.3bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥185.2bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥185.2bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥184.8bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥15.1bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥16.6bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥201.69 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥69.65 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.02 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.33 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.63 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥66 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,212.36 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,109.15 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,116.51 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,117.38 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,098.36 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 64.1% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.8% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.0% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.2% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 17.3% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 160,000,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 165,003,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 170,503,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 170,503,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 170,503,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2,366 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 2,423 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 2,419 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 2,391 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 2,398 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 87
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥402m |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥588m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥138m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥138m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥53.4bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥9.8bn |
| Fine Chemicals Business Unitreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥6.2bn |
| Fine Chemicals Business Unitreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥5.0bn |
| Fine Chemicals Business Unitreportable segment | employees | at 2026-03-31 | 1383 pure |
| Fine Chemicals Business Unitreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥74.2bn |
| Fine Chemicals Business Unitreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥74.1bn |
| Fine Chemicals Business Unitreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥84m |
| Fine Chemicals Business Unitreportable segment | segment assets | at 2026-03-31 | ¥97.0bn |
| Fine Chemicals Business Unitreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥11.9bn |
| Life Science Business Unitreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥5.8bn |
| Life Science Business Unitreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥2.9bn |
| Life Science Business Unitreportable segment | employees | at 2026-03-31 | 943 pure |
| Life Science Business Unitreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥73.0bn |
| Life Science Business Unitreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥73.0bn |
| Life Science Business Unitreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥0 |
| Life Science Business Unitreportable segment | segment assets | at 2026-03-31 | ¥104.1bn |
| Life Science Business Unitreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥9.7bn |
| Mobility And Imaging Business Unitreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥8.1bn |
| Mobility And Imaging Business Unitreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥7.1bn |
| Mobility And Imaging Business Unitreportable segment | employees | at 2026-03-31 | 3360 pure |
| Mobility And Imaging Business Unitreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥94.8bn |
| Mobility And Imaging Business Unitreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥94.7bn |
| Mobility And Imaging Business Unitreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥53m |
| Mobility And Imaging Business Unitreportable segment | segment assets | at 2026-03-31 | ¥144.2bn |
| Mobility And Imaging Business Unitreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥10.7bn |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥20.1bn |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥15.0bn |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥242.0bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥241.9bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥138m |
| —segment total | segment assets | at 2026-03-31 | ¥345.3bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥32.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥20.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥15.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥242.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥241.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥138m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥345.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥32.3bn |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥593m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥196m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥196m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥61.7bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥9.2bn |
| Fine Chemicals Business Unitreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥12.6bn |
| Fine Chemicals Business Unitreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥3.8bn |
| Fine Chemicals Business Unitreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥66.4bn |
| Fine Chemicals Business Unitreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥66.2bn |
| Fine Chemicals Business Unitreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥196m |
| Fine Chemicals Business Unitreportable segment | segment assets | at 2025-03-31 | ¥94.5bn |
| Fine Chemicals Business Unitreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥9.9bn |
| Life Science Business Unitreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥4.8bn |
| Life Science Business Unitreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥2.8bn |
| Life Science Business Unitreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥65.0bn |
| Life Science Business Unitreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥65.0bn |
| Life Science Business Unitreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥0 |
| Life Science Business Unitreportable segment | segment assets | at 2025-03-31 | ¥86.7bn |
| Life Science Business Unitreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥6.4bn |
| Mobility And Imaging Business Unitreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥9.0bn |
| Mobility And Imaging Business Unitreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥6.7bn |
| Mobility And Imaging Business Unitreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥91.4bn |
| Mobility And Imaging Business Unitreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥91.4bn |
| Mobility And Imaging Business Unitreportable segment | segment assets | at 2025-03-31 | ¥130.8bn |
| Mobility And Imaging Business Unitreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥13.3bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥26.5bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥13.3bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥222.8bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥222.6bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥196m |
| —segment total | segment assets | at 2025-03-31 | ¥312.0bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥29.6bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥26.5bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥13.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥222.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥222.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥196m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥312.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥29.6bn |
| Fine Chemicals Business Unitreportable segment | employees | at 2026-03-31 | 696 pure |
| Life Science Business Unitreportable segment | employees | at 2026-03-31 | 889 pure |
| Mobility And Imaging Business Unitreportable segment | employees | at 2026-03-31 | 521 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,193
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss | CurrentYearDuration | 24711000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YearDuration | -4133000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYearDuration | -1036000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YearDuration | -2829000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYearDuration | 14540000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YearDuration | 2507000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYearDuration | 447000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YearDuration | 3000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYearDuration | -12000000 | JPY |
| Other comprehensive income | Prior1YearDuration | -4452000000 | JPY |
| Other comprehensive income | CurrentYearDuration | 13939000000 | JPY |
| Comprehensive income | Prior1YearDuration | 13126000000 | JPY |
| Comprehensive income | CurrentYearDuration | 38650000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YearDuration | 13067000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYearDuration | 38464000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YearDuration | 58000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYearDuration | 186000000 | JPY |
| Net assets | Prior2YearInstant_CapitalStockMember | 14932000000 | JPY |
| Net assets | Prior2YearInstant_CapitalSurplusMember | 15840000000 | JPY |
| Net assets | Prior2YearInstant_RetainedEarningsMember | 199214000000 | JPY |
| Net assets | Prior2YearInstant_TreasuryStockMember | -5413000000 | JPY |
| Net assets | Prior2YearInstant_ShareholdersEquityMember | 224573000000 | JPY |
| Dividends from surplus | Prior1YearDuration_RetainedEarningsMember | -7412000000 | JPY |
| Dividends from surplus | Prior1YearDuration_ShareholdersEquityMember | -7412000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YearDuration_RetainedEarningsMember | 17508000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YearDuration_ShareholdersEquityMember | 17508000000 | JPY |
| Purchase of treasury stock | Prior1YearDuration_TreasuryStockMember | -7875000000 | JPY |
| Purchase of treasury stock | Prior1YearDuration_ShareholdersEquityMember | -7875000000 | JPY |
| Retirement of treasury stock | Prior1YearDuration_CapitalSurplusMember | -15000000 | JPY |
| Retirement of treasury stock | Prior1YearDuration_RetainedEarningsMember | -6595000000 | JPY |
| Retirement of treasury stock | Prior1YearDuration_TreasuryStockMember | 6611000000 | JPY |
| Retirement of treasury stock | Prior1YearDuration_ShareholdersEquityMember | － | JPY |
| Transfer restricted stock based compensation | Prior1YearDuration_CapitalSurplusMember | 8000000 | JPY |
| Transfer restricted stock based compensation | Prior1YearDuration_TreasuryStockMember | 150000000 | JPY |
| Transfer restricted stock based compensation | Prior1YearDuration_ShareholdersEquityMember | 159000000 | JPY |
| Change in treasury shares of parent arising from transactions with non controlling shareholders | Prior1YearDuration_CapitalSurplusMember | 28000000 | JPY |
| Change in treasury shares of parent arising from transactions with non controlling shareholders | Prior1YearDuration_ShareholdersEquityMember | 28000000 | JPY |
| Total changes of items during the period | Prior1YearDuration_CapitalStockMember | － | JPY |
| Total changes of items during the period | Prior1YearDuration_CapitalSurplusMember | 21000000 | JPY |
| Total changes of items during the period | Prior1YearDuration_RetainedEarningsMember | 3500000000 | JPY |
| Total changes of items during the period | Prior1YearDuration_TreasuryStockMember | -1113000000 | JPY |
| Total changes of items during the period | Prior1YearDuration_ShareholdersEquityMember | 2408000000 | JPY |
| Net assets | Prior1YearInstant_CapitalStockMember | 14932000000 | JPY |
| Net assets | Prior1YearInstant_CapitalSurplusMember | 15861000000 | JPY |
| Net assets | Prior1YearInstant_RetainedEarningsMember | 202714000000 | JPY |
| Net assets | Prior1YearInstant_TreasuryStockMember | -6527000000 | JPY |
| Net assets | Prior1YearInstant_ShareholdersEquityMember | 226981000000 | JPY |
| Net assets | Prior2YearInstant_ValuationDifferenceOnAvailableForSaleSecuritiesMember | 16508000000 | JPY |
| Net assets | Prior2YearInstant_ForeignCurrencyTranslationAdjustmentMember | 26241000000 | JPY |
| Net assets | Prior2YearInstant_RemeasurementsOfDefinedBenefitPlansMember | 2237000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |